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Microwave-based stroke diagnosis making global
pre-hospital thrombolytic treatment possible
Mikael Persson, Andreas Fhager, Hana Dobsˇı´cˇek Trefna´, Yinan Yu, Tomas McKelvey,
Go¨ran Pegenius, Jan-Erik Karlsson, Mikael Elam
Abstract—Here we present two different brain diagnostic
devices based on microwave technology and the associated
two first proof of principle measurements that show that the
systems can differentiate hemorrhagic from ischemic stroke in
acute stroke patients, as well differentiate hemorrhagic patients
from healthy volunteers. The system was based on microwave
scattering measurements with an antenna system worn on the
head. Measurement data were analyzed with a machine-learning
algorithm that is based on training using data from patients
with a known condition. CT images were used as reference.
The detection methodology was evaluated with the leave-one-out
validation method combined with a Monte Carlo based bootstrap
step. The clinical motivation for this project is that ischemic
stroke patients may receive acute thrombolytic treatment at
hospitals, dramatically reducing or abolishing symptoms. A
microwave system is suitable for pre-hospital use, and therefore
has the potential to allow significantly earlier diagnosis and
treatment than today.
Index Terms—Microwave system, stroke diagnostics, subspace
distance classification.
I. INTRODUCTION
THE global cost of stroke, including direct health care cost,direct non-medical cost and indirect cost, is hard to assess
but the total 2010 European cost has been estimated to 64.1
billion e [1]. While the cost for society is huge, the human
cost of stroke is horrific. Out of the sufferers of stroke, 5
million people/year die and another 5 million are permanently
disabled [2]. The incidence of stroke in patients below 65
years of age is increasing and presently constitutes 20% of all
strokes. Almost 80% of all strokes are ischemic (obstructed
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blood flow), while the rest are hemorrhagic (bleeding into
brain or on the surface of the brain). In the western world,
stroke is placed third among reasons for acute death, and
first among reasons for neurological dysfunction, resulting in
most days of hospital nursing and therefore the most costly
disease within western world health care [3]. Among stroke
survivors, 20% have serious remaining dysfunctions. A much
larger proportion has less conspicuous dysfunctions, which
still seriously affect quality of life for the patient and relatives.
Early thrombolytic treatment of ischemic stroke is today
an established procedure, [4]–[6], but could be disastrous if
performed on a patient with a hemorrhagic stroke. Computer
Tomography (CT) and sometimes Magnetic Resonance Imag-
ing (MRI) are used to exclude hemorrhagic stroke. The sooner
after onset of symptoms the thrombolytic therapy is initiated,
the better the effect. According to European guidelines, treat-
ment after 4.5h have elapsed since start of symptoms is not
approved as the potential benefit does not outweigh the risk for
hemorrhagic complications, which increases with time. While
20-30% of patients arriving at specialized stroke centers may
receive thrombolytic treatment, [7], [8] only 1-8% of the entire
stroke patient population are given such treatment, [9], mainly
due to long lead times in transport to and from the diagnostic
instruments, [10], [11]. Although solutions for CT scanning in
ambulances have been presented, [12], the global scale of this
clinical dilemma motivates efforts to develop new simplified
diagnostic procedures capable of pre-hospital differentiation
between ischemic and hemorrhagic stroke.
Several different technologies have been researched with
the aim to develop a compact system that can be used
to distinguish ischemic from hemorrhagic stroke in a pre-
hospital setting. Ultrasonography can be used to identify
large vessel occlusions in acute stroke care, [13] but cannot
exclude hemorrhagic transformation of the resulting ischemic
regions. Impedance tomography has been proposed as a pos-
sible technology to detect ICH in an animal model, [14] and
impedance spectroscopy has been suggested as a method to
detect stroke related brain asymmetries in man, [15]. While
less developed in medical diagnostics, microwave propagation
in human tissues has an advantage over both impedance and
ultrasound via the easy penetration of the human scull. This
is the fundamental basis for the present effort.
Microwave imaging techniques for biomedical applications
have been researched for almost three decades. Due to the
inherent scattering nature of propagating microwaves in in-
homogeneous media, computationally very demanding algo-
rithms are used. It is not until the latest 5-10 years that the
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required computational power has become readily available
and that clinically relevant results have been obtained. A large
part of the efforts have been devoted to microwave imaging for
breast cancer detection. Currently this application has come to
a phase of initial clinical studies, [17]–[19] where encouraging
results have been obtained.
The microwave technique is dependent on the existence of
a dielectric contrast between different tissues. A number of
studies of the dielectric properties of different human tissue
have been made, [20]–[23] and there is a clear indication
of a significant contrast between blood and white and gray
brain matter. Originating in our own work with microwave
tomography applied to breast cancer detection, [24], we have
developed a helmet with microwave patch antennas, signal
processing methods based on a machine learning algorithm
and have performed numerical and phantom studies of hem-
orrhagic stroke detection, [25], [26], with encouraging results.
This application is currently attracting increasing interest
among researchers. Recently both numerical studies [27], [28]
as well as a phantom study [29] show the ability to detect the
presence and location of a bleeding stroke inside the skull.
The ambition with our research project is to develop a system
that can be used upon arrival in the emergency room, or by
ambulance personnel at the scene of incident. The relative
simplicity and size of a microwave-based diagnostic system
underlined the possibility of creating an ambulance-based pre-
hospital diagnostic system for stroke patients.
As already mentioned, a mobile CT-equipped stroke unit
enabling pre-hospital diagnosis and treatment has been de-
veloped, and a recent trial showed that it achieved a marked
reduction of latency from symptom-onset to thrombolytic
treatment compared to previous interventional studies [9],
[12]. Although CT-equipped vehicles constitute a formidable
technical achievement, they may primarily be a solution for
countries with a well organized and financed health care
system, densely populated areas with well developed traffic
and telecommunication infrastructure. Affordable and easily
transported equipment for the diagnosis of stroke will re-
main a priority for countries not meeting this description.
A microwave-based system has the advantage of being com-
pletely safe and without side effects. The method also has the
potential of becoming quite cost effective as the component
costs are driven down by the considerably larger telecom
industry. Apart from pre-hospital diagnosis and treatment,
another application of microwave-based stroke detection may
be for monitoring patients undergoing thrombolytic therapy or
patients hospitalized after a transitory ischemic attack.
In this paper we discuss the background, design and signal
analysis of two microwave based stroke detection systems.
We have also performed proof of concept testing using the
two prototype systems on patients and healthy volunteers.
In the first study we used a bicycle helmet, in which 10
patch antennas were mounted. Measurements were performed
using a standard network analyzer and switch box. In the
second study a custom-built helmet with 12 antennas was used.
This time a dedicated and integrated network analyzer and
switching solution were used.
II. MEASUREMENTS
A. Fundamental Principles for Measurements
Stroke diagnosis with a microwave system is based on
measurements and analysis of signals that are transmitted
through the brain. The antennas are distributed over the entire
head to achieve high detection sensitivity. This is illustrated
in Fig. 1. One at a time, each antenna is used as a transmitter,
Figure 1. The 3-d distribution of the isosceles triangle patch antennas
with the remaining antennas in receiving mode, Fig. 2 (a). In
total a large number of transmission measurements are made.
The basis for detection is to analyze the scattered wave pattern
caused by the variations in dielectric contrast in healthy and
normal tissue. The dielectric properties of white and gray
brain matter at the frequency 1.0 GHz has been measured
to r = 38.6, σ = 0.62 S/m and r = 52.3, σ = 0.99
S/m respectively, [20]–[23]. The corresponding properties for
blood has been measured to r = 61.1, σ = 1.58 S/m. The
fact that the properties of blood are different from white and
gray matter also provides the basis for detecting the pool of
blood caused by a hemorrhagic stroke. Also in the case of an
ischemic stroke caused by a blood clot obstructing a vessel,
there exists a basis for detection, Fig. 2 (b). The dielectric
properties are strongly dependent on the circulation of blood
and the oxygenation level. To our knowledge, no in vivo
measurements have been made of the dielectric properties of
a brain area influenced by reduced circulation. However, tests
on bovine brain tissue have shown that dielectric parameters
change as a function of time after death [30]. However, these
measurements were made at a lower frequency range, 20kHz
– 100MHz, than those used in these studies.
B. The Prototype Design Principle
In this section the design of the two systems are described.
In order to provide a comfortable fit, patch antennas with
a flat surface facing the skull were used. To accommodate
varying skull size/shape of patients, containers of soft plastic
were placed between skull and antennas and filled with water
to fill the gap. The use of the plastic containers ensured a
good electromagnetic coupling between the antennas and the
skull. The measurements were made with a two-port network
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(a) Transmission channels (b) Scattering
Figure 2. (a) The transmission channels measured between each antenna pair.
(b) Scattered signal due to accumulated blood pool.
analyzer integrated with a switch matrix module and computer-
controlled in order to automate the measurement procedure
for all antenna pairs. The power was about 1 mW, transmitted
from one antenna at the time. This is about 100 times lower
than the maximum averaged output power of 125 mW that is
transmitted from a GSM-cell phone. No adverse effects are
therefore expected from use of the developed systems.
The patch antennas used in the these two systems were the
same as those used in the hyperthermia applicator developed at
Chalmers [31]. This reference contains a detailed description
of the antenna. In the second system the antennas were slightly
modified with the connector placed on the side of the antenna
rather than on the back. However the change of positions were
made such that the antenna characteristics were unaltered.
This type of antenna is more broadband than for example a
monopole or a dipole. In the present helmet-design the antenna
operates close to the skull, i.e. in the near-field. In addition to
the antenna design the structures in close proximity of the
antenna, e.g. plastic containers, skull, helmet, etc. are also
influencing the antenna performance. The characterization of
the individual antennas and the antenna array must therefore
be made in realistic operating conditions, i.e. when it is worn.
Under such conditions the reflection coefficients show a reso-
nance frequency at 1.2–1.3 GHz. An individual variation can
be seen between antennas, due to the reasons just mentioned.
The reflection coefficient is typically below -10 dB in a 500
MHz band around the resonance frequency. To illustrate this,
the reflection coefficients showing the typical response for
three of the twelve antennas, in the second system, are plotted
in Fig. 3. For the transmission coefficient, the maximum value
is typically found, in the range 0.8-1.3 GHz. The reason
for this lower frequency range is that conductivity of brain
tissue increases with frequency, and that the propagation
distance between different antenna combinations vary. These
two parameters, distance and conductivity, together determine
at which frequency the maximum transmission is obtained.
The resulting maximum transmission coefficient is typically
in the range -20 – -40 dB. Transmission coefficients above -
40 dB are typically found in a band 1.0 – 1.5 GHz around
this maximum, and this is where we expect to obtain the
Figure 3. Examples of reflection coefficients for three different antennas on
the helmet. The remaining antennas show similar characteristics.
best diagnostic performance for our system. In this frequency
range signals propagating through the thickest part of the
head are above the noise floor of the microwave measurement
units, and can thus reliably be detected by all antenna pairs.
In the present studies, every channel was measured over a
large band of frequencies, 0.3–3.0 GHz, which is more than
we expect to be useful. Also the transmission coefficients
are affected by the same variability due to near field effects
as are the reflection coefficients. To exemplify, transmission
coefficients for neighboring antennas, i.e. the pair with the
highest transmission, and the diagonally opposing antennas,
i.e. the antennas with the lowest transmission, have been
plotted in Fig. 4.
Figure 4. Examples of transmission coefficients between the antenna on the
front and the back of the skull, and between the antennas on the front and its
closest neighbor.
At the lower end of the measured frequency band a large
variability is seen in the measurements, even between measure-
ments on the same patient. This can be understood in terms
of capacitive coupling between the antennas, cables and the
surroundings, and makes the measurements less reliable, since
they are influenced by sources originating from outside the
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skull. At the upper end of the frequency scale disturbances can
also be anticipated, both in terms of reduced signal strength
caused by the increasing losses in the tissue, but also due
to variability introduced by the decreased wavelength. When
wearing the helmet there will be individual variations in the
fitting due to the physique of the patient, e.g. skull size,
amount of hair, amount of water in the water containers, and
positioning of the helmet, etc. In terms of wavelengths, these
variations increase with frequency and cause corresponding
uncertainty in the data.
The signal analysis aims at extracting useful information
with respect to the optimal antenna performance range and to
remove the effect of errors. It is however difficult to exactly
determine the limits where the data is useful or not. The
approach in these studies has been to consider the useful
frequency interval as unknown and as a parameter to be
determined in the development procedure and in the clinical
testing.
C. Technical development in preparation for clinical tests
In the development towards a microwave based stroke
diagnostics device the first step was to design an antenna
system that could be fitted on the head and used for microwave
scattering measurements. This was performed as a numerical
study in the simulation software CST [25]. The simulation
was based on a head model from the Visible Human Project
[32] male data set. In this model a spherical volume of blood
was placed in order to simulate a hemorrhagic stroke [25].
The bleeding was centered 45 mm below the skin surface and
positioned just below one antenna. Bleedings ranging 5-30 mm
in radius were used for the simulations. When comparing the
signal with that of a normal brain a detectable variation in
the range 0.5-3 dB in the signal amplitude was found. This
is within practically measurable limits and an encouraging
result. The results are similar when the bleeding is placed
between two antennas, but instead using transmission data for
the detection.
A prototype system was then designed and built. It consisted
of antennas sending and receiving microwave signals, mounted
in a helmet. The helmet is shown in Fig. 5. In this prototype,
ten antennas were used, and they are here visible because
plastic containers for the matching liquid have been partly
removed. In the right part of the helmet, it can however still
be seen. This is the same helmet that was used in the first
patient study.
In this system a total of 45 independent transmit-receive
channels were measured. A single frequency measurement
gives the scattering parameter, and measurements were per-
formed over a large number of frequencies. The microwave
measurement device was a fully computer-controlled system
built on a two-port network analyzer (Agilent E8362 B PNA)
as the transmit/receive unit. To fully automatize the experi-
ment, a 2:32 switch multiplexer module (Cytec CXM/128-S-
W) was used. The channel isolation was 120 dB.
As a next step this system was used in a lab test using tissue
realistic phantom material. The helmet shown in Fig. 5 was
used for these measurements. The aim was to model bleedings
Figure 5. The first prototype system, in which the ten antennas have been
mounted on a bicycle helmet. To the right, in the helmet, plastic bags used
for the matching liquid can be seen.
of different sizes, and to measure and classify these bleedings.
By mixing sugar, salt, water and agar a brain phantom with
the same dielectric properties as gray matter was created,
Fig. 6 (a). Using the same ingredients, with different relative
ratios, phantom material with the same properties as blood was
also created. Measurements were made on the brain phantom,
before and after insertion of blood phantoms of volumes 1,
3, 5 and 10 ml. The measurement data was analyzed with
a subspace distance measure and has been reported in [33].
The results of the analysis are shown in Fig. 6 (b). Two
main features of importance to our detection problem are
worth noting. First, the subspace distances of all cases with a
bleeding included are separated from the non-bleeding case.
Second, the subspace distance is increasing monotonically
with bleeding size. The error-bars show the variation in the
leave one out validation.
During the lab tests and also the first patient study it became
clear that the first prototype was not optimally designed for
its purpose. The main problem was the mechanical strength of
the structures holding the antennas in place were to weak. For
the second patient study a more robust custom built helmet
structure with 12 antennas was constructed, see Fig. 7. This
gave 66 independent transmit-receive channels and a custom
built and integrated network analyzer and switching solution
were used. Specifications of the network analyzer was similar
to the previous system, however signal isolation in the switch
was 80 dB.
III. SIGNAL ANALYSIS
The microwave measurement data, in terms of the scattering
parameters of the transmission channels, were then used
in a hemorrhagic stroke detecting algorithm. The algorithm
was trained using measurements from subjects with known
conditions, i.e. supervised learning. Data from each channel
are pre-processed by scaling the values such that the total
signal power is equal for all channels. The complex values
from all channels are organized into a single complex vector.
Finally, the data is transformed by employing the logarithm
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Figure 6. (a) The brain / blood phantom. (b) The subspace distance plotted
for four different bleeding phantoms.
to each element of the data vector in order to bring the data
to a better numerical range. The algorithm is based on the
assumption that the noise free data vector from subjects with
a hemorrhagic stroke belongs to a linear subspace and that
the corresponding data from subjects with ischemic stroke
belong to another linear subspace. Labeled training data is
used to identify bases for these subspaces. In addition, since
data from both classes share many common features, reduced
size subspaces for each class are formed. This is accomplished
by removing some of the directions in the subspaces that have
the smallest angles between them. The principle of detection in
the algorithm is based on projecting the data sample under test
onto the two reduced subspaces and calculating the Euclidean
distance of the projected data sample. The largest distance
determines which class is selected, i.e. if a hemorrhagic stroke
is detected or not. A decision offset can be introduced to
change the performance of the detector and thereby improve
the probability of detection, at the cost of an increased false
alarm rate. The detection algorithm is a development of the
original idea of a subspace classifier, i.e. CLAFIC, see [16].
So called matched subspace detectors, [34] are also based on
similar ideas. In Section III-A information on measurement
data, its structure and the data pre-processing applied are de-
scribed. A thorough description of the classification algorithm
is presented in Section III-B and the method of validation is
Figure 7. The second prototype system, in which the 12 patch antennas has
been mounted on a custom built supporting structure.
detailed in Section III-C.
A. Measurement data and pre-processing
The raw measurement data provided by the antenna array
system are samples of the complex scattering matrix for
a given set of frequencies. For a fixed frequency ωk, the
scattering matrix element with row index i and column index
j describe the complex gain sij(ω) between the transmission
antenna j and the receiving antenna i. For reciprocal systems
the scattering matrix is symmetric sij(ω) = sji(ω). Hence,
for a reciprocal antenna system with na ports the scattering
matrix has, at most, d = n
2
a+na
2 unique values.
Each matrix element is normalized across the frequency
dimension to equalize the power between channels. The mag-
nitude of the scattering parameters have a large dynamic range.
To mitigate this effect all normalized scattering values are
transformed using the complex logarithm function. Finally
all values from one measurement is embedded into a single
complex vector x ∈ Cd. Hence, the elements of the data vector
x are the elements of the set
{log(sij(ωk)/cij)|k = 1, . . . , nω, 1 ≤ i ≤ j ≤ na} (1)
where nω is the number of measured frequencies and
cij =
√√√√ 1
nω
nω∑
k=1
|sij(ωk)|2 (2)
is the normalization constant.
B. Supervised learning and classification
A detection or classification algorithm is a function which
map the data vector x ∈ Cd into a discrete variable c called
a class label.
c = f(x) (3)
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Here we consider the binary classification problem and hence
c is binary, ie c ∈ {+,−}, a class of positives and a class
of negatives. If a (statistical) model exists describing the un-
derlying mechanism of how samples x and the corresponding
class label are connected, the function f can be derived in
various ways [37]. In supervised learning the function f is
inferred by selecting f from a class of functions based on a
set of available labeled training samples {(ci,xi)}. The stroke
detection algorithm is based on a supervised learning method.
Here the set of classification functions is implicitly defined
by an assumed model of the data. We assume data samples x
corresponding to class c are generated according to
x =
mc∑
k=1
u0c,kαk + e = U
0
cα+ e (4)
where U0c is a matrix containing the basis vectors u
0
c,k as
its columns and α represents the corresponding basis weight
vector for the specific sample x. The vector e is the error
between the model
∑mc
k=1 u
0
c,kαc(k)k and the measurement
x. The integer mc is the dimension of U0c and we assume it
is significantly smaller than the data dimension, ie mc  d.
Estimates of the bases are determined using training data
for each class respectively. All training data samples for one
class is assembled into a matrix
Xc =
[
x1c , x
2
c , · · · , xtcc
]
(5)
where xic denote sample i with label c and tc denote the
number of training samples with label c. Let the Singular value
decomposition (SVD) [38] be given by
Xc =
[
U c U
⊥
c
] [Σc 0
0 Σ⊥c
] [
V c V
⊥
c
]H
(6)
where Σc contains the mc largest singular values of Xc. The
matrix U c ∈ Cd×mc is an estimate of the basis of class c. If
the SNR is high, or if mc  tc the range space of U c will be
approximately the same as the range space of U0c in Eq. 4.
Since the bases of the two classes are derived from samples
of data which are noisy the estimated bases will be perturbed.
Signal directions in the two signal subspaces which are nearly
co-linear will particularly lead to a high variability of the
outcome of the classifier. Hence, dimensions in the two signal
spaces which are nearly co-linear are removed. Proximity
between subspaces are measured using the principal angels.
Definition 1 (Principal angles). [38]
The principal angles 0 ≤ θ1 ≤ . . . ,≤ θm ≤ pi/2 between the
subspaces spanned by U+ ∈ Cd×m+ and U− ∈ Cd×m− are
defined as:
cos(θk) = max
q∈U+ r∈U−
qTr = qTk rk
subject to:
‖q‖ = ‖r‖ = 1
qTqi = 0, r
Tri = 0, i = 1, . . . , k − 1
(7)
where qi and ri are the principal vectors and m =
min(m+,m−).
The vectors q1 and r1 defined by (7) are hence the vectors
from the two spaces spanned by U+ and U− respectively
which have the smallest angle between them. Assuming,
m+ = m− and UH+U+ = U
H
−U− = I , the SVD decompo-
sition of the matrix product UH+U− readily yields a solution
to the principal angle problem.
UH+U− = Y diag(cos θ1, . . . , cos θm)Z
H (8)
Here
Y =
[
y1 y2 · · · ym
]
Z =
[
z1 z2 · · · zm
] (9)
are unitary matrices and diag(cos θ1, . . . , cos θm) is a diagonal
matrix with the non-negative singular values on the diagonal
and
1 ≥ cos θ1 ≥ . . . ≥ cos θm ≥ 0.
Reduced bases with the r closest directions removed are given
by
U r+ = U+
[
yr+1 · · · ym
]
U r− = U−
[
zr+1 · · · zm
]
.
(10)
The discrimination rule is defined by
f(x) =
{
+ when δ(x) + β > 0
− when δ(x) + β ≤ 0 (11)
where
δ(x) = ‖U r+UHr+x‖2 − ‖U r−UHr−x‖2
= xH(U r+U
H
r+ −U r−UHr−)x
(12)
The second equality in Eq. 12 follows since
UHr+U r+ = U
H
r−U r− = I.
The rule can be interpreted as follows. The data vector x is
projected onto the subspaces spanned by the matrices U r+ and
U r− respectively. The label is selected according to which of
the projected vectors have the largest Euclidean length. A non-
zero value of the decision offset β in Eq. 11 can be used to
bias the detection towards class + if β > 0 and towards class
− if β < 0. In comparison with [16], [34] the step where the
nearly co-linear subspaces are removed is here added. This
methodology was introduced in [35], [36].
In the stroke detection application three consecutive mea-
surements are performed on each subject yielding the measure-
ment set {xi|i = 1, 2, 3}. In order to reduce the variance of the
classification result, a modified discrimination rule according
to
f({xi}3i=1) =
{
+ when δ({xi}3i=1) + β > 0
− when δ({xi}3i=1) + β ≤ 0
(13)
is employed where
δ({xi}3i=1) =
1
3
3∑
i=1
‖U r+UHr+xi‖2 − ‖U r−UHr−xi‖2
=
1
3
3∑
i=1
xi
H
(U r+U
H
r+ −U r−UHr−)xi
(14)
which in effect uses the average of the three subspace distances
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as the input to the threshold function in Eq. 13.
C. Performance assessment by cross-validation
The performance of the classification algorithm is measured
by calculating the empirical sensitivity and specificity using
leave-one-out (LOO) cross-validation. In standard LOO cross-
validation, one sample is removed from the training data set
and saved for testing the derived classifier. This procedure
is repeated for all data samples and finally the empirical
performance rates are calculated. The method gives unbiased
performance estimates but has a high variance [37]. In this
application three measurements from each subject are at hand.
A straightforward use of the LOO approach, treating the three
measurements as independent samples, would bias the result
towards an overoptimistic performance. Hence, a modified
LOO validation is employed, where all three data samples
from one subject are removed when forming the training set.
To reduce the variance of the performance estimate, a Monte
Carlo based bootstrap method [39] is used where, in each LOO
step, a sequence of training data sets are formed by randomly
selecting one measurement out of the three for each of the
subject, excluding the LOO subject. For each training data-
set the classification function f(·) is constructed and the data
from the subject left out is tested. The average performance is
then estimated as the empirical outcome over all the randomly
created training sets. In this application 100 random training-
sets are used.
As the classification function is parametrized by the decision
offset β in Eq. 13, the empirical estimates of the performance
measures are a function of this offset. A receiver operator
characteristic (ROC) curve is a visualization of how the
sensitivity and specificity are related by plotting them against
each other [40]. The result is a curve (parametrized by the
offset β) which starts at coordinate (0,1) and ends at (1,0).
The area under this curve (AUC) is a measure of the quality
of the detector. An area of 1 corresponds to the case when
the detector perfectly can separate the two classes and area of
0.5 correspond to a detector which randomly assigns the class
label, e.g. coin-tossing.
IV. CLINICAL TESTING
We have made two consecutive explorative proof of prin-
ciple studies, with the two different prototypes, performed
at different hospital departments at Sahlgrenska University
Hospital. While aiming for a microwave-based investigation
as early upon onset of the stroke as possible, the experimental
nature of the study did not allow a delay of routine clinical
procedures. Only patients with clinically and/or radiologically
established Intra Cerebral Hemorrhage (ICH) or Ischemic
Stroke (IS), without a history of previous cerebrovascular
events, were included in the studies. In each investigation,
three consecutive microwave measurements were performed.
Patient safety follow up was performed one day after the
microwave-based investigation. Written, informed consent was
obtained from each patient, before any study related procedure
was initiated. The studies were approved by the local Ethical
Review Board, and conducted according to Good Clinical
Practice and the revised Declaration of Helsinki.
A. The first clinical study
The first study was performed at the department of clinical
neurophysiology by engineering and neurophysiology staff.
Here we summarize the main results from this study, per-
formed with the same device used for our phantom studies (cf
above, Fig. 5). The device was used to investigate 20 patients,
diagnosed with acute stroke. The patients were studied in a
time window of 7-132 hours after stroke onset, defined as
last awareness of healthy condition. Out of the 20 patients
enrolled, 9 patients were suffering from ICH and 11 patients
from IS. Table I in the Appendix provides more detailed data
about the patients. Scattering measurements in the frequency
range from 885-1670 MHz were used in this study. Given the
limited number of patients in the study, the LOO Monte Carlo
approach described in Section III-C was used to assess the
performance of the algorithm on these data.
The resulting Receiver Operating Characteristic (ROC)
curve is shown in Fig. 8. The area under the curve (AUC)
is 0.88 gives an indication of the strength of the detection
algorithm. This result is obtained by removing 4 nearly co-
linear dimensions resulting in a final subspace dimension of
4. Finally, the scatterplot in Fig. 9 shows the averaged squared
subspace distance difference for each patient based on a leave-
one-out validation method: The patients are arranged along
the x-axis according to the time between stroke onset and the
measurement occasion. With the hemorrhagic detector aimed
at identifying all 9 patients with an ICH, 7 out of 11 IS patients
were separated from the ICH group whereas 4 were not.
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Figure 8. Summary of detector performance illustrated as an empirical ROC
curve for ICH vs IS patients. The empirical performance is based on data
from MF01 study and is obtained using a LOO Monte Carlo method. The
ROC curves are parametrized by the decision offset β in (11). The area under
the ROC curve (AUC) is 0.88.
B. The second clinical study
The second study was performed bedside within a neu-
rology ward, by nursing staff. The patients were studied in
a time window of 4-27 hours after stroke onset, defined
as last awareness of healthy condition. The performance
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Figure 9. Illustration of the distribution of the decision variable, the difference
between the squared subspaces distances evaluated for all patients in a leave-
one-out validation. The x-axis corresponds to elapsed time from onset of
stroke to time of measurement. Data is from ICH vs IS in first clinical study.
of the microwave measurement system with the associated
algorithm was evaluated on the clinical data generated by
measurements on 25 hospitalized stroke patients. Out of the
25 patients enrolled, 10 patients were suffering from ICH and
15 patients from IS, see Table II in the Appendix for more
detailed information. The nurses performing the microwave-
based assessment were blinded regarding the result of clinical
and radiological investigations performed at admission. In
addition, a group of healthy control subjects (n=65, 36 male,
age range 23-74), recruited via advertisements within the
hospital and university, were investigated.
The available data was grouped into two classes. In each
case all measurements from patients with a bleeding stroke
formed one class (ICH 10 subjects). The second class was
formed in one of the following two ways:
1) Data from patients with an ischemic stroke (IS 15
subjects)
2) Data from healthy subjects (healthy 65 subjects)
We will refer to these test cases as 1) ICH vs IS, 2) ICH vs
healthy. In each of the cases the objective of the detection is to
discriminate ICH subjects from the others. The measurement
bandwidth utilized was 857-1493 MHz and in the classification
algorithm we remove 5 nearly co-linear dimensions resulting
in a final subspace dimension of 4. The results from the
detection of ICH patients, expressed as empirical probabil-
ities from the Monte Carlo investigations are summarized in
Figures 10-12. The resulting Receiver Operating Characteristic
(ROC) curves are shown in Figure 10 where the upper graph
illustrates the ICH vs IS case and the lower graph the ICH vs
healthy case. The ICH vs IS case gave an AUC of 0.85, and
ICH vs healthy case resulted in an AUC of 0.87. Note that
the performance is increased when more subjects are included
in the training data as compared to the base-line ICH vs IS
case. Best performance is obtained when we discriminate ICH
patients from healthy volunteers. In Figure 11 it is illustrated
how different values of the decision offset β influence the
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Figure 10. Summary of detector performance illustrated as empirical ROC
curves for ICH vs IS patients (upper graph) and ICH vs Healthy group (lower
graph). The empirical performance is based on data from MF02 Study and is
obtained using the Monte Carlo method. The ROC curves are parametrized
by the decision offset β in (11). The area under the ROC curve (AUC) is
indicated in the legend of the plot for each graph.
sensitivity and specificity. The upper graph is for the ICH
vs IS case and the lower graph is for the ICH vs healthy
case. Finally, Figure 12 depicts a scatter plot from test case
1, ICH vs IS, illustrating the averaged squared subspace
distance difference for each patient, based on the leave-one-
out validation method. The patients are arranged along the
x-axis according to the time elapsed between stroke onset
and measurement. With the hemorrhagic detector aimed at
identifying all 10 patients with an ICH, 14 out of 15 IS patients
were clearly separated from the ICH group whereas 1 was
not. As shown in Figure 12, the variability of the results is
increased for patients measured 10h after stroke onset.
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Figure 11. Summary of detector performance illustrated as how the Sensitivity
and Specificity varies with the decision offset β in (11). for for ICH vs IS
patients (upper graph) and ICH vs Healthy group (lower graph). The empirical
performance is based on data from MF02 Study and is obtained using a Monte
Carlo method.
V. DISCUSSION
We have designed and built microwave-based measurement
systems that can differentiate ICH from IS in acute stroke
patients and ICH patients from healthy volunteers. Results
from two different clinical pilot-studies demonstrate the effec-
tiveness and limitations of the method developed. The finding,
that our first- and second-generation systems generated similar
stroke detection results is interesting as the two studies where
made with completely different prototypes, performed at two
separate departments at the hospital. Our continued clinical
studies will evaluate improved analysis paradigms, as well
as non-rigid caps carrying the antennas, with the ultimate
aim to introduce a simple and affordable pre-hospital stroke
diagnostic procedure.
The classification algorithms used for these two studies
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Figure 12. Illustration of the distribution of the decision variable, the
difference between the squared subspaces distances evaluated for all patients
in a leave-one-out validation. The x-axis corresponds to elapsed time from
onset of stroke to time of measurement. Data is from case 1 ICH vs IS in
MF02 study.
were derived using labeled sets of training data. The results
in Figure 10 show an increased performance when healthy
patients are used for training. That the comparison of ICH vs
65 healthy controls gave a better performance than the compar-
ison ICH vs 15 IS was an expected finding, in all probability
due to IS related brain edema increasing with the latency from
IS onset. At 99.9% sensitivity to detect ICH, the proportion
of IS patients safely differentiated was approximately 30%,
whereas at 90% ICH sensitivity 65% of IS patients could
be differentiated. A larger data-set resulting from an ongoing
clinical study involving several hospitals in Sweden, aiming
for as early investigation as possible, is expected to increase
the predictive power of the algorithms, i.e. the capacity for
ICH vs IS differentiation. However, even without such an
improvement, the differentiating capacity reported here is of
considerable clinical interest given the low percentage of
ischemic stroke patients presently being diagnosed in time
to get thrombolytic treatment (cf introduction). In a recent
Swedish trial, a higher priority level given to stroke patients
by the pre-hospital emergency medical service reduced time
to arrival at a stroke unit and increased the percentage of
patients receiving thrombolytic treatment from 10 to 24%,
[41]. Adding reasonably safe pre-hospital information about
type of stroke may be expected to improve these figures
further, as well as the pre-hospital treatment and triage, [9].
Needless to say, an introduction of pre-hospital thrombolytic
treatment based on a microwave scan diagnosis will have to
await studies of larger clinical cohorts, and a full clinical
translation can only be achieved when stroke clinicians in
a non-blinded bedside situation can compare data provided
by microwave-based classification to clinical status and other
diagnostic procedures. Furthermore, we have presented the
measurement system as a stroke detector and illustrated the
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performance in terms of sensitivity and specificity measures
in order to illustrate the merits of the system. However, the
detector is based on comparing two derived measures, i.e.
the sizes of the measured signal projected onto the subspaces
representing each class. In a clinical setting we believe the
physician will directly use these continuous measures in order
to complement other diagnostic sources before making a final
diagnosis.
VI. CONCLUSION
For the first time proof of principle have been presented that
microwave-based measurements can differentiate ICH from IS
in acute stroke patients as well differentiate ICH from healthy
volunteers. The relative simplicity and size of microwave-
based systems compared to CT or MR scanners make them
easily applicable in a pre-hospital setting. We suggest that
microwave technology could result in a substantial increase of
patients reaching a stroke diagnosis in time for introduction
of thrombolytic treatment. The socioeconomic ramifications
of such a development are obvious not only in the industrial
world but also, and perhaps even more so, in the developing
world.
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APPENDIX A
PATIENT AND STROKE CHARACTERISTICS, CLINICAL STUDY 1
Table I
PATIENT AND STROKE CHARACTERISTICS, CLINICAL STUDY 1. ABBREVIATIONS: NIHSS NATIONAL INSTITUTES OF HEALTH STROKE SCALE, IS -
ISCHEMIC STROKE, ICH - INTRACEREBRAL HAEMORRHAGE, F - FRONTAL, T - TEMPORAL, O - OCCIPITAL, P - PARIETAL, BG - BASAL GANGLIA, INS -
INSULA, THAL - THALAMUS.
Age Gender Diagnosis Site of lesion Volume(ml)
Latency stroke
to study
(h:min)
NIHSS at
investigation
39 F IS Right F 137 132:00 22
73 F ICH Left F 19 25:00 9
56 F IS Left T 16 55:05 14
68 M IS Right TO 29 77:10 5
59 M IS Left F 25 49:55 10
55 M IS Left FTP 287 128:00 14
64 F ICH Left BG 10 60:40 5
65 M ICH Left TP 19 19:38 7
65 M IS Right FTP 99 62:13 14
79 F ICH Right BG 3,3 26:10 7
64 F IS Right BG 6,0 94:20 4
76 M IS Left F, INS 22 47:10 11
46 F IS Left FTP 139 37:15 8
62 M ICH Right BG 6,8 36:10 4
86 M ICH Left BG 3,2 7:30 4
62 M ICH Left BG 17 23:35 18
70 F ICH Right THAL 4,0 21:15 5
53 M ICH Left THAL 0,5 19:40 2
37 M IS Right TF 53 26:05 1
64 F IS Left TO 47 27:55 13
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APPENDIX B
PATIENT AND STROKE CHARACTERISTICS, CLINICAL STUDY 2
Table II
ABBREVIATIONS: NIHSS - NATIONAL INSTITUTES OF HEALTH STROKE SCALE, IS - ISCHEMIC STROKE, ICH INTRACEREBRAL HAEMORRHAGE, F -
FRONTAL, T - TEMPORAL, O - OCCIPITAL, P - PARIETAL, BG - BASAL GANGLIA, INS - INSULA, THAL - THALAMUS, CAPS E - CAPSULA EXTERNA,
COR RAD - CORONA RADIATA, VENT PEN VENTRICULAR PENETRATION, SAH PEN - SUBARACHNOIDAL HAEMORRHAGE PENETRATION, C SEMI
CENTRUM SEMIOVALE, SDH - SUBDURAL HAEMORRHAGE.
Age Gender Diagnosis Site of lesion Volume(ml)
Latency stroke
to study
(h:min)
NIHSS at
investigation
58 F IS Left FT, INS 36 18:10 2
73 F IS Right P 6,1 15:30 2
84 F IS Left CAPS E, INS 3,8 16:15 1
83 F ICH Left BG, VENT PEN 3,6 16:35 12
79 F IS Right COR RAD 0,7 10:30 2
68 M ICH Left FP, SAH PEN 13 26:45 13
89 F ICH Left C SEMI 2,5 21:30 22
40 M ICH Left BG 18 24:20 12
85 F IS Right T, INS 19 23:35 1
76 M IS Right F, BG 105 14:30 18
86 F IS Right F 2,2 25:05 6
60 M IS Right COR RAD 1,1 15:00 1
74 M IS Not visualized - 20:55 0
53 F ICH Left THAL, VENT PEN 17 10:42 17
59 M ICH Left BG 2,4 4:28 4
65 F IS Right TP 48 21:52 1
83 F IS Left F 12 21:02 3
86 M IS Not visualized - 4:57 9
62 M IS Right COR RAD 3,2 24:55 8
80 F ICH Right FP, SDH 18 13:16 10
89 F IS Left FT 206 19:27 26
82 F IS Right TP 38 6:27 17
61 F ICH Left BG, VENT PEN 35 20:05 22
89 F ICH Right BG, VENT PEN 82 23:44 11
67 F ICH Left THAL 3,1 11:28 7
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